Refine by
Aposcience Clinical Trials Equipment & Supplies In China
2 equipment items found
Manufactured by:Aposcience AG based inVienna, AUSTRIA
The target population are those over 700,000 patients worldwide who undergo reperfusion treatment for acute ST-elevation myocardial infarction. If APO-1 (APOSECTM) proves effective in clinical trials, the market potential is estimated at 1 – 2 billion Euros ...
Manufactured by:Aposcience AG based inVienna, AUSTRIA
The company expects that products derived from PBMCs will have a significant impact in the care for millions of patients who are afflicted by poorly healing wounds (diabetic foot ulcers, ischemic ulcerations, pressure ulcers) and therefore present a very important market opportunity. If efficacy can be demonstrated in clinical trials, a turnover of well over 1 ...